Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The swiss HIV cohort study

Lancet

Volumn 356, Issue 9244, 2000, Pages 1800-1805

  Greub, G ^a   Ledergerber, B ^b   Battegay, M ^c   Grob, P ^b   Perrin, L ^d   Furrer, H ^e   Burgisser, P ^a   Erb, P ^f   Boggian, K ^g   Piffaretti, J C ^h   Hirschel, B ^d   Janin, P ⁱ   Francioli, P ⁱ   Flepp, M ^b   Telenti, A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^h Istituto Batteriosierologico Cantonale   (Switzerland)

ⁱ SHCS Data Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; DISEASE COURSE; DRUG POTENCY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SUPERINFECTION; SURVIVAL;

EID: 0034715950     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03232-3     Document Type: Article

References (35)

1. A multicenter study of viral hepatitis in a United States hemophilic population
2. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995
3. Hepatitis C virus infection and progression of infection due to human immunodeficiency virus
4. Hepatitis C virus infection in patients infected with the human immunodeficiency virus
5. Hepatitis C in HIV-infected patients with and without AIDS: Prevalence and relationship to patient survival
6. Hepatitis C virus and human immunodeficency virus: Clinical issues of coinfection
7. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?
8. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus positive hemophilics and should be treated as an opportunistic infection
9. Coinfection of hepatitis C virus with immunodeficiency virus and progression to AIDS
10. Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease
11. Determinants of the quantity of hepatitis C virus RNA
12. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections
13. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV
14. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters
15. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy
16. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C
17. Natural history of hepatitis C virus infection in multitranfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study
18. Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
19. Progression of HIV infection in misusers of injected drugs who stopped injecting or followed a program of maintenance treatment with methadone
20. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression
21. Partial residuals for the proportional hazards regression model
22. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
23. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection
24. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: The Swiss HIV Cohort Study
25. The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1
26. Binding of hepatitis C virus to CD81
27. Presence of hepatitis C virus (HCV) genomic RNA and viral replicative intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients
28. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers
29. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: Evidence of active replication in monocytes/macrophages and lymphocytes
30. Hepatitis C virus genotypes and quasispecies
31. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men
32. Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group
33. Management of chronic hepatitis C in HIV-infected patients
34. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users
35. Pathogenesis, natural history, treatment, and prevention of hepatitis C